Kcentra Kit
Product Images NDC 63833-387

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Kcentra (NDC 63833-387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Kcentra 01)

Kcentra plasma derivative kit by CSL Behring GmbH, shown with three vials including one vial inside a plastic cup with a peel-back seal. The vial in the cup has a blue cap, and the other two separately displayed vials have one white and one blue cap, respectively. The image depicts the kit components but no visible strength or detailed labeling.*

FDA Label Image

Figure 2 (Kcentra 02)

Kcentra kit components include a clear plastic reconstitution device with a blue connector and a sealed transparent glass vial with a blue cap. The vial is intended for use with the reconstitution device in preparation of the plasma-derived therapy by CSL Behring GmbH.*

FDA Label Image

Figure 3 (Kcentra 03)

An instructional illustration showing a two-part clear plastic cap being removed or placed onto a blue and clear vial with a rubber stopper, representing a step in preparing the Kcentra plasma derivative kit for use.*

FDA Label Image

Figure 4 (Kcentra 04)

An instructional illustration showing three components of the Kcentra plasma derivative kit: a clear vial with a blue cap at the top, a white connector piece in the middle, and a smaller clear vial with a silver cap at the bottom, with a downward blue arrow indicating assembly or connection direction.*

FDA Label Image

Figure 5 (Kcentra 05)

Kcentra plasma derivative kit consisting of two clear glass vials with liquid contents. The vial on the left has a white cap and a brown collar, and the vial on the right has a blue cap. A separate blue plastic flip-off cap is also shown in front of the vials. Both vials have white labels with black text and barcodes, but the text is not readable in the image. The kit is labeled by CSL Behring GmbH.*

FDA Label Image

Figure 6 (Kcentra 06)

An instructional illustration showing a step in the assembly or preparation of the Kcentra plasma derivative kit. The image includes two vial or container components aligned vertically with a blue cap on the top vial and an arrow indicating a twisting motion to attach or detach the parts.*

FDA Label Image

Figure 7 (Kcentra 07)

Clear glass vial for Kcentra plasma derivative kit from CSL Behring GmbH, featuring a white plastic stopper and a transparent cap holder. The vial is empty and displayed upright with blue arrows indicating it may rotate or twist, suggesting vial handling instructions.*

FDA Label Image

Figure 8 (Kcentra 08)

An illustration showing a medical vial and a syringe with an arrow indicating the syringe plunger moving downward to withdraw or inject fluid into the vial. This depicts a step in the preparation or administration process typically associated with injectable medications or kits.*

FDA Label Image

Figure 9 (Kcentra 09)

Kcentra plasma derivative kit components showing a clear glass vial connected to a transparent syringe with a plunger and a black stopper in the vial. The image highlights the assembly or administration setup of the product by CSL Behring GmbH.*

FDA Label Image

Figure 10 (Kcentra 10)

An instructional illustration showing how to use or assemble a medical kit component consisting of a syringe connected to a small vial or container, with an arrow indicating rotation of the vial to attach or detach it from the syringe. The image likely relates to preparation or administration steps for the Kcentra plasma derivative kit.*

FDA Label Image

Figure 9 (Kcentra 11)

A set of six line graphs comparing the mean percentage of normal levels of Factor IX, Factor II, Factor VII, Factor X, Protein C, and Protein S over 24 hours after start of infusion. Each graph differentiates between Kcentra and Plasma treatments, showing their respective changes in factor/protein levels over time.*

FDA Label Image

Principal Display Panel (500 U Vial Label)

Packaging label for Kcentra 500 U Range Prothrombin Complex Concentrate (Human) kit by CSL Behring GmbH. The label highlights that the kit contains lyophilized factor IX concentrate, factors II, VII, X, and proteins C and S. It includes storage instructions, manufacturer and distributor information, ingredient amounts, and cautions about potential infectious agents.*

FDA Label Image

Principal Display Panel (500 U Kit Carton)

Packaging label for Kcentra 1000 U Range Prothrombin Complex Concentrate (Human) kit by CSL Behring GmbH. The label states it contains a single-dose vial with 800-1240 units of lyophilized Factor IX concentrate and other coagulation factors for intravenous administration only. Storage instructions and manufacturing details are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.